Postal Ballot Notice- Change in objects of utilization of IPO proceeds
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 1.9 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Earkart Ltd, a hearing aid manufacturer listed on BSE (scrip code 544549), is seeking shareholder approval via postal ballot to reallocate unutilized IPO proceeds of approximately Rs 14.13 crore (from a total fresh issue of Rs 3,906.79 lakhs raised in FY 2025-26). The company proposes to shift Rs 1,304.69 lakhs from its Shop in Shop (SIS) capital expenditure object to fund working capital expansion (Rs 500 lakhs), a newly added pharmaceutical business initiative (Rs 250 lakhs), and land/property acquisitions (Rs 400 lakhs). The SIS capex budget is being cut from Rs 1,733.26 lakhs to Rs 383.26 lakhs, despite the company not yet having entered into any agreements with the 574 identified clinic locations. The resolution requires approval by more than 90% of voting shareholders under SEBI ICDR regulations, with an exit offer mandated for dissenting shareholders.
The significant reallocation away from the core SIS expansion strategy and into unrelated pharmaceutical and real estate ventures raises concerns about the original IPO's stated objectives. This could signal weak IPO execution or strategic pivot, and warrants close monitoring of fund utilization and future business performance.